Form 8-K - Current report:
SEC Accession No. 0000950170-23-059451
Filing Date
2023-11-06
Accepted
2023-11-06 16:30:36
Documents
58
Period of Report
2023-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K dawn-20231106.htm   iXBRL 8-K 57791
2 EX-99.1 dawn-ex99_1.htm EX-99.1 108903
3 EX-99.2 dawn-ex99_2.htm EX-99.2 55733
4 GRAPHIC img109617361_0.jpg GRAPHIC 9664
5 GRAPHIC dawn-ex99_2s1.jpg GRAPHIC 167482
6 GRAPHIC dawn-ex99_2s2.jpg GRAPHIC 624268
7 GRAPHIC dawn-ex99_2s3.jpg GRAPHIC 370568
8 GRAPHIC dawn-ex99_2s4.jpg GRAPHIC 321362
9 GRAPHIC dawn-ex99_2s5.jpg GRAPHIC 146673
10 GRAPHIC dawn-ex99_2s6.jpg GRAPHIC 496815
11 GRAPHIC dawn-ex99_2s7.jpg GRAPHIC 409739
12 GRAPHIC dawn-ex99_2s8.jpg GRAPHIC 388933
13 GRAPHIC dawn-ex99_2s9.jpg GRAPHIC 370604
14 GRAPHIC dawn-ex99_2s10.jpg GRAPHIC 471642
15 GRAPHIC dawn-ex99_2s11.jpg GRAPHIC 166101
16 GRAPHIC dawn-ex99_2s12.jpg GRAPHIC 286973
17 GRAPHIC dawn-ex99_2s13.jpg GRAPHIC 354553
18 GRAPHIC dawn-ex99_2s14.jpg GRAPHIC 340306
19 GRAPHIC dawn-ex99_2s15.jpg GRAPHIC 164025
20 GRAPHIC dawn-ex99_2s16.jpg GRAPHIC 426387
21 GRAPHIC dawn-ex99_2s17.jpg GRAPHIC 431625
22 GRAPHIC dawn-ex99_2s18.jpg GRAPHIC 447558
23 GRAPHIC dawn-ex99_2s19.jpg GRAPHIC 621403
24 GRAPHIC dawn-ex99_2s20.jpg GRAPHIC 414250
25 GRAPHIC dawn-ex99_2s21.jpg GRAPHIC 318357
26 GRAPHIC dawn-ex99_2s22.jpg GRAPHIC 162528
27 GRAPHIC dawn-ex99_2s23.jpg GRAPHIC 405641
28 GRAPHIC dawn-ex99_2s24.jpg GRAPHIC 167275
29 GRAPHIC dawn-ex99_2s25.jpg GRAPHIC 353303
30 GRAPHIC dawn-ex99_2s26.jpg GRAPHIC 438354
31 GRAPHIC dawn-ex99_2s27.jpg GRAPHIC 354452
32 GRAPHIC dawn-ex99_2s28.jpg GRAPHIC 128882
33 GRAPHIC dawn-ex99_2s29.jpg GRAPHIC 318279
34 GRAPHIC dawn-ex99_2s30.jpg GRAPHIC 240544
35 GRAPHIC dawn-ex99_2s31.jpg GRAPHIC 308145
36 GRAPHIC dawn-ex99_2s32.jpg GRAPHIC 491573
37 GRAPHIC dawn-ex99_2s33.jpg GRAPHIC 340513
38 GRAPHIC dawn-ex99_2s34.jpg GRAPHIC 324668
39 GRAPHIC dawn-ex99_2s35.jpg GRAPHIC 367680
40 GRAPHIC dawn-ex99_2s36.jpg GRAPHIC 352165
41 GRAPHIC dawn-ex99_2s37.jpg GRAPHIC 400138
42 GRAPHIC dawn-ex99_2s38.jpg GRAPHIC 364494
43 GRAPHIC dawn-ex99_2s39.jpg GRAPHIC 548112
44 GRAPHIC dawn-ex99_2s40.jpg GRAPHIC 342851
45 GRAPHIC dawn-ex99_2s41.jpg GRAPHIC 311990
46 GRAPHIC dawn-ex99_2s42.jpg GRAPHIC 321258
47 GRAPHIC dawn-ex99_2s43.jpg GRAPHIC 465480
  Complete submission text file 0000950170-23-059451.txt   21382370

Data Files

Seq Description Document Type Size
48 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dawn-20231106_lab.xml EX-101.LAB 13350
49 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dawn-20231106_pre.xml EX-101.PRE 9842
50 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dawn-20231106.xsd EX-101.SCH 2472
52 EXTRACTED XBRL INSTANCE DOCUMENT dawn-20231106_htm.xml XML 4730
Mailing Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005 650 484-0899
Day One Biopharmaceuticals, Inc. (Filer) CIK: 0001845337 (see all company filings)

EIN.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40431 | Film No.: 231380367
SIC: 2834 Pharmaceutical Preparations